| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BYL-719 | CTRPv2 | pan-cancer | AAC | -0.014 | 0.8 |
| mRNA | BRD-K85133207 | CTRPv2 | pan-cancer | AAC | 0.012 | 0.8 |
| mRNA | Rapamycin | CTRPv2 | pan-cancer | AAC | 0.011 | 0.8 |
| mRNA | GSK-J4 | CTRPv2 | pan-cancer | AAC | 0.031 | 0.8 |
| mRNA | isoliquiritigenin | CTRPv2 | pan-cancer | AAC | -0.021 | 0.8 |
| mRNA | OSI-930 | CTRPv2 | pan-cancer | AAC | -0.011 | 0.8 |
| mRNA | valdecoxib | CTRPv2 | pan-cancer | AAC | -0.011 | 0.8 |
| mRNA | ML312 | CTRPv2 | pan-cancer | AAC | 0.023 | 0.8 |
| mRNA | JW-55 | CTRPv2 | pan-cancer | AAC | -0.023 | 0.8 |
| mRNA | alisertib | CTRPv2 | pan-cancer | AAC | 0.0091 | 0.8 |